| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Dec 01, 2025 | Sale | $29.30 | 4,000 | 117,200 | 65,740 | Dec 01, 2025, 05:41 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Nov 03, 2025 | Option/RSU Exercise | $19.34 | 5,000 | 96,700 | 78,740 | Nov 03, 2025, 04:37 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Nov 03, 2025 | Sale | $30.38 | 9,000 | 273,442 | 69,740 | Nov 03, 2025, 04:37 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Oct 15, 2025 | Option/RSU Exercise | $19.34 | 5,000 | 96,700 | 82,740 | Oct 15, 2025, 06:47 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Oct 15, 2025 | Sale | $31.53 | 9,000 | 283,776 | 73,740 | Oct 15, 2025, 06:47 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 26, 2025 | Option/RSU Exercise | - | 6,866 | - | 80,789 | Feb 28, 2025, 05:16 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 26, 2025 | Tax Payment (Shares) | $34.79 | 3,049 | 106,090 | 77,740 | Feb 28, 2025, 05:16 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 22, 2025 | Tax Payment (Shares) | $35.32 | 5,452 | 192,565 | 69,648 | Feb 25, 2025, 06:35 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 22, 2025 | Option/RSU Exercise | - | 12,279 | - | 75,100 | Feb 25, 2025, 06:35 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 23, 2025 | Tax Payment (Shares) | $35.32 | 3,414 | 120,582 | 73,923 | Feb 25, 2025, 06:35 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 23, 2025 | Option/RSU Exercise | - | 7,689 | - | 77,337 | Feb 25, 2025, 06:35 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 18, 2025 | Tax Payment (Shares) | $35.90 | 3,950 | 141,805 | 62,821 | Feb 20, 2025, 05:13 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 18, 2025 | Option/RSU Exercise | - | 8,896 | - | 66,771 | Feb 20, 2025, 05:13 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 12, 2025 | Option/RSU Exercise | $19.64 | 199,196 | 3,912,871 | 262,796 | Feb 14, 2025, 05:12 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 12, 2025 | Sale | $32.78 | 204,921 | 6,718,277 | 90,983 | Feb 14, 2025, 05:12 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 13, 2025 | Option/RSU Exercise | $30.12 | 144,419 | 4,350,097 | 202,294 | Feb 14, 2025, 05:12 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 13, 2025 | Sale | $35.53 | 144,419 | 5,130,698 | 166,708 | Feb 14, 2025, 05:12 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 06, 2025 | Tax Payment (Shares) | $31.39 | 15,083 | 473,455 | 63,600 | Feb 07, 2025, 08:31 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jan 30, 2025 | Option/RSU Exercise | $22.22 | 97,632 | 2,169,137 | 145,208 | Jan 31, 2025, 08:42 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jan 30, 2025 | Sale | $32.05 | 100,918 | 3,234,381 | 44,290 | Jan 31, 2025, 08:42 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Dec 09, 2024 | Option/RSU Exercise | $22.70 | 48,997 | 1,112,259 | 108,727 | Dec 09, 2024, 08:53 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Dec 09, 2024 | Sale | $32.07 | 61,151 | 1,961,406 | 47,576 | Dec 09, 2024, 08:53 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Dec 05, 2024 | Sale | $31.50 | 9,221 | 290,462 | 59,730 | Dec 05, 2024, 06:01 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Dec 04, 2024 | Sale | $30.77 | 14,349 | 441,550 | 68,951 | Dec 04, 2024, 04:52 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Nov 11, 2024 | Option/RSU Exercise | $20.03 | 43,058 | 862,452 | 142,296 | Nov 12, 2024, 04:48 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Nov 11, 2024 | Sale | $30.08 | 58,996 | 1,774,576 | 83,300 | Nov 12, 2024, 04:48 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Nov 06, 2024 | Sale | $29.53 | 10,471 | 309,169 | 99,238 | Nov 06, 2024, 07:47 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 23, 2024 | Tax Payment (Shares) | $29.57 | 3,414 | 100,952 | 109,709 | Feb 27, 2024, 04:03 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 23, 2024 | Option/RSU Exercise | - | 7,689 | - | 113,123 | Feb 27, 2024, 04:03 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 22, 2024 | Tax Payment (Shares) | $28.91 | 5,452 | 157,617 | 105,434 | Feb 23, 2024, 04:07 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 22, 2024 | Option/RSU Exercise | - | 12,278 | - | 110,886 | Feb 23, 2024, 04:07 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 20, 2024 | Option/RSU Exercise | - | 10,297 | - | 103,180 | Feb 21, 2024, 05:32 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 18, 2024 | Tax Payment (Shares) | $32.18 | 3,951 | 127,143 | 92,883 | Feb 21, 2024, 05:32 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 18, 2024 | Option/RSU Exercise | - | 8,897 | - | 96,834 | Feb 21, 2024, 05:32 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 20, 2024 | Tax Payment (Shares) | $30.39 | 4,572 | 138,943 | 98,608 | Feb 21, 2024, 05:32 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 08, 2024 | Tax Payment (Shares) | $26.77 | 15,280 | 409,046 | 87,937 | Feb 12, 2024, 09:57 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 22, 2023 | Option/RSU Exercise | - | 12,038 | - | 61,904 | Feb 24, 2023, 08:23 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 22, 2023 | Tax Payment (Shares) | $27.77 | 5,345 | 148,431 | 56,559 | Feb 24, 2023, 08:23 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 18, 2023 | Option/RSU Exercise | - | 8,722 | - | 26,716 | Feb 22, 2023, 04:56 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 20, 2023 | Tax Payment (Shares) | $28.07 | 10,306 | 289,289 | 46,044 | Feb 22, 2023, 04:56 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 20, 2023 | Option/RSU Exercise | - | 10,095 | - | 34,155 | Feb 22, 2023, 04:56 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 21, 2023 | Tax Payment (Shares) | $27.77 | 3,053 | 84,782 | 49,866 | Feb 22, 2023, 04:56 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 21, 2023 | Option/RSU Exercise | - | 6,875 | - | 52,919 | Feb 22, 2023, 04:56 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 18, 2023 | Tax Payment (Shares) | $28.07 | 2,656 | 74,554 | 24,060 | Feb 22, 2023, 04:56 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 23, 2022 | Sale | $24.76 | 11,983 | 296,650 | 17,994 | Feb 24, 2022, 05:34 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 21, 2022 | Option/RSU Exercise | - | 6,875 | - | 23,501 | Feb 23, 2022, 04:40 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 22, 2022 | Tax Payment (Shares) | $25.01 | 3,539 | 88,510 | 29,977 | Feb 23, 2022, 04:40 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 18, 2022 | Sale | $25.17 | 2,306 | 58,042 | 9,496 | Feb 23, 2022, 04:40 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 22, 2022 | Option/RSU Exercise | - | 12,037 | - | 33,516 | Feb 23, 2022, 04:40 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 20, 2022 | Tax Payment (Shares) | $25.08 | 2,966 | 74,387 | 16,626 | Feb 23, 2022, 04:40 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 20, 2022 | Option/RSU Exercise | - | 10,096 | - | 19,592 | Feb 23, 2022, 04:40 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 21, 2022 | Tax Payment (Shares) | $25.08 | 2,022 | 50,712 | 21,479 | Feb 23, 2022, 04:40 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 16, 2022 | Option/RSU Exercise | - | 3,375 | - | 12,871 | Feb 17, 2022, 04:24 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 16, 2022 | Tax Payment (Shares) | $26.79 | 1,069 | 28,639 | 11,802 | Feb 17, 2022, 04:24 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sep 14, 2021 | Tax Payment (Shares) | $30.60 | 5,647 | 172,798 | 9,496 | Sep 16, 2021, 04:25 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jun 09, 2021 | Sale | $24.60 | 882 | 21,697 | 0 | Jun 11, 2021, 04:36 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jun 07, 2021 | Tax Payment (Shares) | $23.50 | 368 | 8,648 | 882 | Jun 08, 2021, 06:51 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jun 07, 2021 | Option/RSU Exercise | - | 1,250 | - | 1,250 | Jun 08, 2021, 06:51 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Apr 15, 2021 | Sale | $19.72 | 28,920 | 570,288 | 0 | Apr 16, 2021, 04:35 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 20, 2021 | Tax Payment (Shares) | $19.58 | 3,064 | 59,993 | 24,067 | Feb 23, 2021, 09:25 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 20, 2021 | Option/RSU Exercise | - | 10,095 | - | 27,131 | Feb 23, 2021, 09:25 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 21, 2021 | Tax Payment (Shares) | $19.58 | 2,022 | 39,591 | 28,920 | Feb 23, 2021, 09:25 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 21, 2021 | Option/RSU Exercise | - | 6,875 | - | 30,942 | Feb 23, 2021, 09:25 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 16, 2021 | Option/RSU Exercise | - | 3,375 | - | 18,208 | Feb 18, 2021, 07:25 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 16, 2021 | Tax Payment (Shares) | $19.79 | 1,172 | 23,194 | 17,036 | Feb 18, 2021, 07:25 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 21, 2020 | Option/RSU Exercise | - | 6,875 | - | 15,955 | Jan 15, 2021, 04:37 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jun 07, 2020 | Tax Payment (Shares) | $17.19 | 368 | 6,326 | 14,833 | Jun 08, 2020, 04:21 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jun 07, 2020 | Option/RSU Exercise | - | 1,250 | - | 15,201 | Jun 08, 2020, 04:21 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 21, 2020 | Option/RSU Exercise | - | 6,875 | - | 15,955 | Feb 24, 2020, 04:13 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 21, 2020 | Tax Payment (Shares) | $20.24 | 2,004 | 40,561 | 13,951 | Feb 24, 2020, 04:13 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 16, 2020 | Tax Payment (Shares) | $17.77 | 1,172 | 20,826 | 9,080 | Feb 18, 2020, 04:10 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 16, 2020 | Option/RSU Exercise | - | 3,375 | - | 10,252 | Feb 18, 2020, 04:10 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | SVP, Med Dev/Med Affairs, CMO | Jun 07, 2019 | Tax Payment (Shares) | $22.83 | 368 | 8,401 | 6,877 | Jun 10, 2019, 05:13 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | SVP, Med Dev/Med Affairs, CMO | Jun 07, 2019 | Option/RSU Exercise | - | 1,250 | - | 7,245 | Jun 10, 2019, 05:13 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | SVP, Med Dev/Med Affairs, CMO | Feb 16, 2019 | Option/RSU Exercise | - | 3,375 | - | 7,078 | Feb 19, 2019, 07:03 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | SVP, Med Dev/Med Affairs, CMO | Feb 16, 2019 | Tax Payment (Shares) | $32.54 | 1,083 | 35,241 | 5,995 | Feb 19, 2019, 07:03 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | SVP, Med Dev/Med Affairs, CMO | Dec 07, 2018 | Tax Payment (Shares) | $34.01 | 1,178 | 40,064 | 3,703 | Dec 11, 2018, 07:43 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | SVP, Med Dev/Med Affairs, CMO | Jun 07, 2018 | Tax Payment (Shares) | $48.30 | 369 | 17,823 | 881 | Jun 08, 2018, 05:31 PM |
| ALKS | | Alkermes plc. | Craig C. Hopkinson | SVP, Med Dev/Med Affairs, CMO | Jun 07, 2018 | Option/RSU Exercise | - | 1,250 | - | 1,250 | Jun 08, 2018, 05:31 PM |
